Stock Research for AEZS

AEZS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AEZS Stock Chart & Research Data

The AEZS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AEZS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AEZS Due diligence Resources & Stock Charts

The AEZS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AEZS Detailed Price Forecast - CNN Money CNN View AEZS Detailed Summary - Google Finance
Yahoo View AEZS Detailed Summary - Yahoo! Finance Zacks View AEZS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AEZS Trends & Analysis - Trade-Ideas Barrons View AEZS Major Holders - Barrons
NASDAQ View AEZS Call Transcripts - NASDAQ Seeking View AEZS Breaking News & Analysis - Seeking Alpha
Spotlight View AEZS Annual Report - CompanySpotlight.com OTC Report View AEZS OTC Short Report - OTCShortReport.com
TradeKing View AEZS Fundamentals - TradeKing Charts View AEZS SEC Filings - Bar Chart
WSJ View Historical Prices for AEZS - The WSJ Morningstar View Performance/Total Return for AEZS - Morningstar
MarketWatch View the Analyst Estimates for AEZS - MarketWatch CNBC View the Earnings History for AEZS - CNBC
StockMarketWatch View the AEZS Earnings - StockMarketWatch MacroAxis View AEZS Buy or Sell Recommendations - MacroAxis
Bullish View the AEZS Bullish Patterns - American Bulls Short Pains View AEZS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AEZS Stock Mentions - StockTwits PennyStocks View AEZS Stock Mentions - PennyStockTweets
Twitter View AEZS Stock Mentions - Twitter Invest Hub View AEZS Investment Forum News - Investor Hub
Yahoo View AEZS Stock Mentions - Yahoo! Message Board Seeking Alpha View AEZS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AEZS - SECform4.com Insider Cow View Insider Transactions for AEZS - Insider Cow
CNBC View AEZS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AEZS - OTC Markets
Yahoo View Insider Transactions for AEZS - Yahoo! Finance NASDAQ View Institutional Holdings for AEZS - NASDAQ


Stock Charts

FinViz View AEZS Stock Insight & Charts - FinViz.com StockCharts View AEZS Investment Charts - StockCharts.com
BarChart View AEZS Stock Overview & Charts - BarChart Trading View View AEZS User Generated Charts - Trading View




Latest Financial News for AEZS


Aeterna Zentaris: 4Q Earnings Snapshot
Posted on Tuesday March 26, 2019

The Summerville, South Carolina-based company said it had a loss of 31 cents per share. The drug developer posted revenue of $1.4 million in the period. For the year, the company reported net income of ...


Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results
Posted on Tuesday March 26, 2019

Aeterna Zentaris Inc. (AEZS) (AEZS) today reported its financial and operating results for the fourth quarter and year ended December 31, 2018. The increase in total revenue in 2018 relates to license fees, royalty income and product sales associated with executing the License and Assignment Agreement for Macrilen™ (macimorelin) in January 2018.


Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019
Posted on Tuesday March 19, 2019

Aeterna Zentaris Inc. (AEZS) (AEZS) will announce its fourth quarter and year ended December 31, 2018 financial and operating results after market close on Tuesday, March 26, 2019. Aeterna Zentaris Inc. is a specialty biopharmaceutical company focused on commercializing novel pharmaceutical therapies, principally through out-licensing arrangements. Aeterna Zentaris is a party to a license and assignment agreement with a subsidiary of Novo Nordisk A/S to carry out development, manufacturing, registration and commercialization of Macrilen™ (macimorelin) in the United States and Canada.


Aeterna Zentaris (AEZS) Moves to Buy: Rationale Behind the Upgrade
Posted on Monday March 18, 2019

Aeterna Zentaris (AEZS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).


Stock Market & Investing Books

Enter a stock symbol to view the stock details.